VIDO Secures New Funding to Tackle the Threat of Avian Influenza
VIDO has received funding to expand its research on high-path avian influenza (HPAI), commonly known as bird flu.
VIDO has received funding to expand its research on high-path avian influenza (HPAI), commonly known as bird flu.
VIDO has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract by the United States’ National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
Six universities across Canada have partnered to develop a cutting edge One Health training, mentorship and education program.